An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis

Atiq, Omair, Tiro, Jasmin, Yopp, Adam C., Muffler, Adam, Marrero, Jorge A., Parikh, Neehar D., Murphy, Caitlin, McCallister, Katharine +1 more·2017·Hepatology
DOI 10.1002/hep.28895

Cited by (266)

Items 101–200 of 266

  1. Benefits and harms of screening for hepatocellular carcinoma in high-risk populations: systematic review and meta-analysis
    Jichun Yang, Zhirong Yang, Xueyang Zeng, Shuqing Yu, Le Gao, Yu Jiang, Feng Sun · 2023 · Journal of the National Cancer Center
  2. Platelets’ RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules
    Walifa Waqar, Sidra Asghar, Sobia Manzoor · 2021 · PLoS ONE
  3. Addition of [18F]Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography to Cross‐Sectional Imaging Improves Staging and Alters Management in Hepatocellular Carcinoma
    Binu V. John, Sean Aubuchon, Bassam A Dahman, Venkata Rajesh Konjeti, Douglas M. Heuman, Jennifer Hubert, Smitha Thomas, Yangyang Deng, Cynthia Solomon, Latha Thankam Sundaram et al. · 2020 · Liver Transplantation
  4. Weighing the benefits of hepatocellular carcinoma surveillance against potential harms
    Daniel Geh, Fahd A. Rana, Helen Louise Reeves · 2019 · Journal of Hepatocellular Carcinoma
  5. Hepatocellular carcinoma surveillance in Australia: current and future perspectives
    Samuel Hui, Sally Bell, Suong T. T. Le, Anouk T Dev · 2023 · The Medical Journal of Australia
  6. Advancing Surveillance Strategies for Hepatocellular Carcinoma: A New Era of Efficacy and Precision
    Amit G. Singal, Michelle Ng, Anand L Kulkarni · 2024 · Journal of Clinical and Experimental Hepatology
  7. External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy
    Honglian Gui, Yan Huang, Gangde Zhao, Lichang Chen, Wei Cai, Hui Wang, Qing Guo, Qing Xie · 2021 · Frontiers in Medicine
  8. Proportion of Time Covered by Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis
    Darine Daher, Karim Seif El Dahan, Sruthi Yekkaluri, Purva Gopal, Nicole E. Rich, Neehar D. Parikh, Caitlin C. Murphy, Amit G. Singal · 2023 · The American Journal of Gastroenterology
  9. Hepatocellular carcinoma surveillance, early detection and survival in a privately insured US cohort
    Vincent Lingzhi Chen, Amit G. Singal, Elliot B. Tapper, Neehar D. Parikh · 2020 · Liver International
  10. Performance of GALAD, GAAD, and ASAP for Early HCC Detection in Chronic Liver Disease: A Systematic Review and Meta-Analysis
    Mohammad Jarrah, Ashwini Arvind, Purva Gopal, Sneha Deodhar, Ju Dong Yang, Neehar D. Parikh, Amit G. Singal · 2025 · Liver Cancer
  11. A 2-Step Strategy Combining FIB-4 With Transient Elastography and Ultrasound Predicted Liver Cancer After HCV Cure
    Javier Ampuero, Isabel Carmona, Francisca Sousa, José Miguel Rosales Zábal, M.A. López-Garrido, Marta Casado, Banca Figueruela, Ana Aparicio, Raúl J. Andrade, María Fernanda Guerra Veloz et al. · 2021 · The American Journal of Gastroenterology
  12. Application of a deep learning algorithm for the diagnosis of HCC
    Philip L. H. Yu, Keith Wan-Hang Chiu, Jianliang Lu, Gilbert C.S. Lui, Jian Zhou, Ho Ming Cheng, Xianhua Mao, Juan Wu, Xinping Shen, King Ming Kwok et al. · 2024 · JHEP Reports
  13. Combinatorial Gene Expression Profiling of Serum HULC, HOTAIR, and UCA1 lncRNAs to Differentiate Hepatocellular Carcinoma from Liver Diseases: A Systematic Review and Meta-Analysis
    Lalita Lumkul, Phatcharida Jantaree, Kritsada Jaisamak, Wasinee Wongkummool, Worakitti Lapisatepun, Santhasiri Orrapin, Sasimol Udomruk, Luca Lo Piccolo, Parunya Chaiyawat · 2024 · International Journal of Molecular Sciences
  14. Hepatocellular Carcinoma Surveillance and Staging
    Amit G. Singal, Neehar D. Parikh, Nicole E. Rich, Binu V. John, Anjana A Pillai · 2019 · Molecular and translational medicine
  15. Surveillance for hepatocellular cancer
    Anna Roskilly, Ian A.C. Rowe · 2018 · Clinical Medicine
  16. Serial increase and high alpha‐fetoprotein levels predict the development of hepatocellular carcinoma in 6 months
    Tung‐Hung Su, Shan-Han Chang, Chi‐Ling Chen, Sih‐Han Liao, Tai‐Chung Tseng, Shih–Jer Hsu, Chun‐Ming Hong, Chen‐Hua Liu, Hung‐Chih Yang, Chun‐Jen Liu et al. · 2023 · Hepatology Research
  17. Exploiting targeted nanomedicine for surveillance, diagnosis, and treatment of hepatocellular carcinoma
    Tingting Liu, Li Liu, Li Li, Jing Cai · 2023 · Materials Today Bio
  18. Hepatocellular carcinoma surveillance with ultrasound—cost-effectiveness, high-risk populations, uptake
    Maxime Ronot, Romain Pommier, Marco Dioguardi Burgio, Yvonne Purcell, Pierre Nahon, Valérie Vilgrain · 2018 · British Journal of Radiology
  19. Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients
    Coşkun Özer Demirtaş, Feyza Gündüz, Davut Tüney, Feyyaz Baltacıoğlu, Haluk Tarık Kani, Onur Buğdaycı, Yeşim Özen Alahdab, Osman Cavit Özdoğan · 2019 · European Journal of Gastroenterology & Hepatology
  20. Simple Clinical Metrics Enhance AFP to Effectively Identify Cirrhotic Patients With Complicating Hepatocellular Carcinoma at Various AFP Levels
    Xi Zhang, Ting Wang, Kun-He Zhang, Sihai Chen, Yuting He, Yuqi Wang · 2020 · Frontiers in Oncology
  21. Cost-Effectiveness Analysis of Hepatocellular Carcinoma Surveillance in Nonalcoholic Fatty Liver Disease Cirrhosis Using US Visualization Score C–Triggered Abbreviated MRI
    Ashwini Mulgaonkar, Daniel Q. Huang, Harris Siddiqi, Kathryn Jane Fowler, Claude B. Sirlin, Robert M. Marks, Rohit Seth Loomba, Gauree Gupta Konijeti · 2023 · The American Journal of Gastroenterology
  22. PNPLA3 risk allele is associated with risk of hepatocellular carcinoma but not decompensation in compensated cirrhosis
    Esteban Urias, Nicholas R. Tedesco, Daniel A. Burkholder, Isabel J. Moran, Matthew J. Miller, Venkata Sai J. Jasty, Snehal B. Patil, Sebastian Zoellner, Karn Wijarnpreecha, Vincent Lingzhi Chen · 2024 · Hepatology Communications
  23. Liquid Liver Biopsy for Disease Diagnosis and Prognosis
    Desislava K. Tsoneva, Martin N. Ivanov, Manlio Vinciguerra · 2023 · Journal of Clinical and Translational Hepatology
  24. Hepatocellular carcinoma surveillance among people living with hepatitis B in Senegal (SEN-B): insights from a prospective cohort study
    Adrià Ramírez Mena, Mbaye Thiam, Daye Kà, Ibrahima Niang, Judicaël Malick Tine, Louise Fortes, Kiné Ndiaye, Ousseynou Ndiaye, Ndèye Maguette Fall, Assietou Gaye et al. · 2024 · The Lancet. Gastroenterology & hepatology
  25. Hepatocellular carcinoma surveillance: Eastern and Western perspectives
    Yvonne Purcell, Pauline Copin, Luisa Paulatto, Romain Pommier, Valérie Vilgrain, Maxime Ronot · 2018 · ULTRASONOGRAPHY
  26. External validation of aMAP risk score in patients with chronic hepatitis C genotype 4 and cirrhosis who achieved SVR following DAAs
    Gamal El-Sayed Shiha, Nabiel N. H. Mikhail, Reham Soliman · 2020 · Journal of Hepatology
  27. Machine Learning Identifies a Signature of Nine Exosomal RNAs That Predicts Hepatocellular Carcinoma
    Josephine Yu Yan Yap, Laura Shih Hui Goh, Ashley J. W. Lim, Samuel S. Chong, Lee Jin Lim, Caroline Guat Lay Lee · 2023 · Cancers
  28. Ultrasound LI-RADS Visualization Scores on Surveillance Ultrasound for Hepatocellular Carcinoma: A Systematic Review With Meta-analysis
    Ji Hun Kang, Nam Hee Kim, Dong Hwan Kim, Yangsean Choi, Joon‐Il Choi · 2023 · Ultrasound in Medicine & Biology
  29. Clinician-Level Knowledge and Barriers to Hepatocellular Carcinoma Surveillance
    Robert J. Wong, Patricia Denise Jones, Bolin Niu, George Therapondos, Mae Thamer, Onkar S. Kshirsagar, Yi Zhang, Paulo Sérgio Pinheiro, Beverly Kyalwazi, Ronnie Fass et al. · 2024 · JAMA Network Open
  30. Liver Transplantation in the Time of COVID19: Barriers and Ethical Considerations for Management and Next Steps
    Ariel Jaffe, Michael L. Schilsky, Ranjit P. Deshpande, Ramesh Batra · 2020 · Hepatology Communications
  31. Is hepatocellular carcinoma surveillance in high-risk populations effective?
    Kristeen Onyirioha, Sukul Mittal, Amit G. Singal · 2020 · Hepatic Oncology
  32. Analysis of Hepatocellular Carcinoma Tissue for Biomarker Discovery
    Connor A. West, Alyson P. Black, Anand S. Mehta · 2019 · Molecular and translational medicine
  33. Imaging Modalities for Hepatocellular Carcinoma Surveillance: Expanding Horizons beyond Ultrasound
    Hyo Jung Park, So Yeon Kim · 2020 · Journal of Liver Cancer
  34. Small Nucleolar RNAs and Their Comprehensive Biological Functions in Hepatocellular Carcinoma
    Xiaoyu Liu, Wan Xie, Silu Meng, Xiaoyan Kang, Yuhuan Liu, Lili Guo, Changyu Wang · 2022 · Cells
  35. Guideline for stratified screening and surveillance in patients with high risk of primary liver cancer (2020)
    Huiguo Ding, Hong Tu, Chunfeng Qu, Guangwen Cao, Hui Zhuang, Ping Zhao, Xiaoyuan Xu, Yongping Yang, Shichun Lu, Prevention of Infection Related Cancer (PIRCA) Group · 2021 · Hepatoma Research
  36. Surveillance for hepatocellular carcinoma: current status and future perspectives for improvement
    Bernardo Stefanini, Matteo Tonnini, Ilaria Serio, Matteo Renzulli, Francesco Tovoli · 2022 · Expert Review of Anticancer Therapy
  37. Biomarker Development Using Liquid Biopsy in Hepatocellular Carcinoma
    Lauren Tal Grinspan, Augusto Villanueva · 2022 · Seminars in Liver Disease
  38. Hepatocellular Carcinoma Risk Scores Predict Patients Under Surveillance at Low Risk of Benefit and High Risk of Harm
    Chris Curran, Matthew Priest, Shouren Datta, Ewan H. Forrest, Adrian John Stanley, Stephen T. Barclay · 2022 · Digestive Diseases and Sciences
  39. Surveillance for Hepatocellular Carcinoma
    Jorge A. Marrero · 2020 · Clinics in Liver Disease
  40. Recommended 10-Year Follow-Up Strategy for Small Hepatocellular Carcinoma After Radiofrequency Ablation: A Cost-Effectiveness Evaluation
    Qifeng Chen, Song Chen, Jun‐Zhe Yi, Jiong-Liang Wang, Sui-Xing Zhong, Xiongying Jiang, Yue Hua Hu, Gen-Jun Tan, Jie Xu, Ning Lyu et al. · 2024 · The American Journal of Gastroenterology
  41. Cost-effectiveness analysis of artificial intelligence (AI) in earlier detection of liver lesions in cirrhotic patients at risk of hepatocellular carcinoma in Italy
    L. Maas, C. Contreras-Meca, Samuele Ghezzo, Flore Belmans, Andrea Corsi, Jeroen Cant, Wim G. Vos, M. Bobowicz, Marlena Rygusik, Dariusz Łaski et al. · 2025 · Journal of Medical Economics
  42. Risk Factors of Hepatocellular Carcinoma for Precision Personalized Care
    Naoto Fujiwara, Po‐Hong Liu, Sai Krishna Athaluri Divakar, Shijia Zhu, Yujin Hoshida · 2019 · Molecular and translational medicine
  43. Biomarker analysis of fucosylated kininogen through depletion of lectin reactive heterophilic antibodies in hepatocellular carcinoma
    Mengjun Wang, Jiabin Shen, Harmin Herrera, Amit G. Singal, Charles S. Swindell, LU Renquan, Anand S. Mehta · 2018 · Journal of Immunological Methods
  44. Benefits and harms of hepatocellular carcinoma screening outreach in patients with cirrhosis: a multicenter randomized clinical trial
    Amit G. Singal, Darine Daher, Manasa Narasimman, Sruthi Yekkaluri, Yan Liu, Vanessa Cerda, Chaitra Banala, Aisha Khan, MinJae Lee, Karim Seif El Dahan et al. · 2024 · JNCI Journal of the National Cancer Institute
  45. Gene body hypomethylation of pyroptosis-related genes NLRP7, NLRP2, and NLRP3 facilitate non-invasive surveillance of hepatocellular carcinoma
    Haikun Zhang, Peiling Dong, Hailang Fan, Hao Liang, Ke Zhang, Yaqian Zhao, Shicheng Guo, Steven J. Schrodi, Yubo Fan, Dake Zhang · 2023 · Functional & Integrative Genomics
  46. Standardizing liver imaging reporting and interpretation: LI-RADS and beyond
    Nicole E. Rich, Victoria Chernyak · 2023 · Hepatology Communications
  47. A high-throughput mass cytometry barcoding platform recapitulating the immune features for HCC detection
    Yongtao Ji, Dongpeng Sun, Yaxing Zhao, Jiao Tang, Jianghui Tang, Jinyuan Song, Junlei Zhang, Xun Wang, Wei Shao, Dong Chen et al. · 2023 · Nano Today
  48. Hepatocellular Carcinoma Surveillance
    Janice H. Jou, Andrew Joseph Muir · 2017 · Clinical Gastroenterology and Hepatology
  49. Screening for Hepatocellular Carcinoma in HIV-Infected Patients: Current Evidence and Controversies
    Nicolás Merchante, Miguel Rodríguez-Fernández, Juan Antonio Pineda · 2020 · Current HIV/AIDS Reports
  50. Hepatocellular carcinoma surveillance in Australia: time to improve the diagnosis of cirrhosis and use liver ultrasound
    Gary P. Jeffrey, Louisa G. Gordon, Grant A. Ramm · 2020 · The Medical Journal of Australia
  51. Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs
    Jacob Søholm, Janne Fuglsang Hansen, Belinda Klemmensen Mössner, Birgit Thorup Røge, Alex Lund Laursen, Jesper Bach Hansen, Nina M Weis, Toke Seierøe Barfod, Suzanne Lunding, Anne Lindebo Holm Øvrehus et al. · 2020 · PLoS ONE
  52. Multicenter evaluation of abbreviated MRI and ultrasound for detecting early-stage hepatocellular carcinoma
    Karim Seif El Dahan, Takeshi Yokoo, Darine Daher, Matthew S. Davenport, David T. Fetzer, Mishal Mendiratta‐Lala, Nicole E. Rich, Edward Yang, Neehar D. Parikh, Amit G. Singal · 2025 · JHEP Reports
  53. Impact of age on clinical outcomes among patients with hepatocellular carcinoma: A systematic review and meta-analysis
    Olgert Bardhi, Darine Daher, Mausam J. Patel, Karim Seif El Dahan, Nicole E. Rich, Sukul Mitta, Neehar D. Parikh, Anjana A Pillai, Laura Kulik, Ju Dong Yang et al. · 2025 · JHEP Reports
  54. Patient-Perceived Risk of Hepatocellular Carcinoma and Net Benefit of Surveillance: A Multicenter Survey Study
    Amit G. Singal, Ju Dong Yang, Prasun K. Jalal, Reena J. Salgia, Neil J. Mehta, Maarouf A. Hoteit, Karissa Kao, Darine Daher, Karim Seif El Dahan, Perla Hernandez et al. · 2025 · The American Journal of Gastroenterology
  55. Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis
    Mohammad Azharul Karim, Amit G. Singal, Hye‐Chung Kum, Yi‐Te Lee, Sulki Park, Nicole E. Rich, Mazen Noureddin, Ju Dong Yang · 2023 · Cancer Research Communications
  56. Eliciting Patient Preferences for Hepatocellular Carcinoma Screening: A Choice-Based Conjoint Analysis
    Soudabeh Fazeli Dehkordy, Yesenia Covarrubias, Shirin Bassirian, Jordan Cuevas, Kathryn Jane Fowler, Irine Vodkin, Yuko Kono, Robert M. Marks, Rohit Seth Loomba, Bachir A. Taouli et al. · 2022 · Journal of the American College of Radiology
  57. Histological Severity of Cirrhosis Influences Surgical Outcomes of Hepatocellular Carcinoma After Curative Hepatectomy
    Bin-yong Liang, Jin Gu, Min Xiong, Erlei Zhang, Zun-Yi Zhang, W. Y. Lau, Shaofa Wang, Yan Guan, Xiaoping Chen, Zhiyong Huang · 2022 · Journal of Hepatocellular Carcinoma
  58. The Performance of Serum Alpha-Fetoprotein for Detecting Early-Stage Hepatocellular Carcinoma Is Influenced by Antiviral Therapy and Serum Aspartate Aminotransferase: A Study in a Large Cohort of Hepatitis B Virus-Infected Patients
    Xiangjun Qian, Yanna Liu, Fengping Wu, Siyu Zhang, Jiao Gong, Yuemin Nan, Bo Hu, Junhui Chen, Jingmin Zhao, Xiangmei Chen et al. · 2022 · Viruses
  59. Cost-Effectiveness of a Biomarker-Based Screening Strategy for Hepatocellular Carcinoma in Patients with Cirrhosis
    Amit G. Singal, Jagpreet Chhatwal, Neehar D. Parikh, Elliot B. Tapper · 2024 · Liver Cancer
  60. Older Age But Not Comorbidity Is Associated With Worse Survival in Patients With Hepatocellular Carcinoma
    Mounika Kanneganti, Mohammed Al-Hasan, Samantha Bourque, Sneha Deodhar, Ju Dong Yang, Daniel Q. Huang, Anand V. Kulkarni, Purva Gopal, Neehar D. Parikh, Fasiha Kanwal et al. · 2024 · Clinical Gastroenterology and Hepatology
  61. Hepatocellular carcinoma surveillance with liver imaging is not associated with improved survival
    Sonja Lang, Anna Martin, Philipp Kasper, Christoph Schramm, Fabian Kütting, Tobias Goeser, Hans‐Michael Steffen, Münevver Demir · 2020 · Scandinavian Journal of Gastroenterology
  62. Surveillance of hepatocellular carcinoma in cirrhotic patients: Current knowledge and future directions
    Coşkun Özer Demirtaş, Osman Cavit Ozdogan · 2020 · Hepatology forum/Hepatology forum (Online)
  63. Advanced electrochemical nanobiosensor for ultraefficient Annexin A2 biomarker detection: A rapid, label free and minimal invasive approach towards early diagnosis of liver cancer
    Dipti Chauhan, Ramesh Chandra, Suveen Kumar · 2021 · Materials Letters
  64. Impact of ultrasonographic blind spots for early-stage hepatocellular carcinoma during surveillance
    Junghwan Lee, Su Bee Park, Soyoung Byun, Ha Il Kim · 2022 · PLoS ONE
  65. Expanding the Boundaries for Liver Transplantation for Hepatocellular Carcinoma
    Jessica D. Lindemann, Maria B. Majella Doyle · 2023 · Surgical Clinics of North America
  66. Dual-Functionalized Glass Micropipette Sensor for Simultaneous High Sensitivity Detection of Cancer Biomarkers
    Guofeng Wang, Shiwei Xu, Yueyue Feng, Liying Huang, Yajun Wang, Nannan Liu · 2025 · ACS Applied Materials & Interfaces
  67. Hepatocellular Carcinoma Surveillance
    Eden Koo, Amit G. Singal · 2023 · Surgical Oncology Clinics of North America
  68. Imaging and Biomarker Approaches to HCC Surveillance
    Piyush Nathani, Amit G. Singal · 2021 · Clinical Liver Disease
  69. DETECT: Development of Technologies for Early HCC Detection
    Jihane N. Benhammou, Nicole E. Rich, George T. Cholankeril, Peng Zhang, Weihua Zeng, Shuyun Rao, Nabihah Tayob, Wenyuan Li, Xiaoli Wu, Shuo Feng et al. · 2022 · Gastroenterology
  70. ctDNA as a novel and promising approach for cancer diagnosis: a focus on hepatocellular carcinoma
    Negin Biglari, Mohammad Sadegh Soltani‐Zangbar, Jamal Mohammadian, Amir Mehdizadeh, Khadijeh Abbasi · 2023 · EXCLI journal
  71. The Future Role of Abdominal US in Hepatocellular Carcinoma Surveillance
    Mishal Mendiratta‐Lala, David T. Fetzer, Aya Kamaya, Neehar D. Parikh, Amit G. Singal · 2024 · Radiology
  72. MicroRNA in HCC: Biomarkers and Therapeutic Targets
    Zheng Wang, Yongxia He, Yuwei Song, Yue Wang, Feng Chen · 2021 · ONCOLOGIE
  73. MAFLD, HCC and the dilemma of (changing) terminology in liver diseases
    Rubén Hernáez, Markus Peck‐Radosavljevic · 2022 · Gut
  74. Enhancing Hepatocellular Carcinoma Surveillance: Comparative Evaluation of AFP, AFP-L3, DCP and Composite Models in a Biobank-Based Case-Control Study
    Coşkun Özer Demirtaş, Sehnaz Akin, Demet Karadağ, Tuba Yilmaz, Uğur Çiftçi, Javid Hüseynov, Tuğba Tolu, Yasemin Kaldirim Armutcuoglu, Feyza Dilber, Osman Cavit Özdoğan et al. · 2025 · Cancers
  75. Performance of the multi-target hepatocellular carcinoma blood test: Design and rationale of the ALTUS study
    Binu V. John, Mark Camardo, Kyle M. Porter, Paul Z. Elias, Elle Kielar‐Grevstad, Seema P. Rego, Neehar D. Parikh, Lewis Rowland Roberts, Alvin C. Silva, Amit G. Singal et al. · 2025 · Hepatology Communications
  76. ACR Appropriateness Criteria® Staging and Follow-Up of Primary Liver Cancer
    Elainea N. Smith, Mustafa R. Bashir, Alice Fung, Brooks D. Cash, Matthew R. Dixon, Elizabeth M. Hecht, Brendan M. McGuire, Anjana A Pillai, Gregory K. Russo, Rachna T. Shroff et al. · 2025 · Journal of the American College of Radiology
  77. Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study
    Jagpreet Chhatwal, Sumeyye Samur, Ju Dong Yang, Lewis Rowland Roberts, Mindie H. Nguyen, Ahmet Burak Ozbay, Turgay Ayer, Neehar D. Parikh, Amit G. Singal · 2023 · Hepatology Communications
  78. Development and Validation of a Risk Score for Liver Cirrhosis Prediction in Untreated and Treated Chronic Hepatitis B
    An K. Le, Hwai‐I Yang, Ming‐Lun Yeh, Mingjuan Jin, Huy Ngoc Trinh, Linda L Henry, Anne Liu, Jian Q. Zhang, Jiayi Li, Christopher Wong et al. · 2020 · The Journal of Infectious Diseases
  79. Practice changing RCT design and rationale: Abbreviated MRI plus AFP vs. ultrasound plus AFP for HCC surveillance in cirrhosis (PREMIUM study)
    George N. Ioannou, Tamar Hamosh Taddei, Beata M. Planeta, Grant D. Huang, Noel S. Weiss, Timothy R.M. Morgan, Jason A. Dominitz, Ghassan K. Abou‐Alfa, Mustafa R. Bashir, Michael V. Beheshti et al. · 2025 · JHEP Reports
  80. Comparison of Annual Dynamic Abbreviated MRI and Biannual Ultrasound for HCC Surveillance in a High-Risk Group: Two-Center Cohort Study
    Jeong Hee Yoon, Joon-Il Choi, Jeongin Yoo, Sun Kyung Jeon, Jae Hyun Kim, Jae Seok Bae, Hyo-Jin Kang, Hokun Kim, Seo Yeon Youn, Dong Hwan Kim et al. · 2025 · Liver Cancer
  81. Persisting challenges in the early detection of hepatocellular carcinoma
    Ashwini Arvind, K. Redmon, Amit G. Singal · 2025 · Expert Review of Anticancer Therapy
  82. Surveillance for patients at risk of hepatocellular carcinoma: how to improve its cost-effectiveness and expand the role of multidisciplinary tumor board?
    Lorenzo Lani, Giacomo Zaccherini, Edoardo Giovanni Giannini, Franco Trevisani · 2025 · Hepatoma Research
  83. Effectiveness of noncontrast-abbreviated magnetic resonance imaging in a real-world hepatocellular carcinoma surveillance
    Hyun Kyung Yang, Sunyoung Lee, Min Young Lee, Myeong‐Jin Kim · 2025 · European Radiology
  84. MiRNA-122 association with TNF-α in some liver diseases of Egyptian patients
    Ahmed Abdelhalim Yameny, Sabah Alabd, Magda Mansor · 2023 · Journal of Bioscience and Applied Research/Journal of Bioscience and Applied Research
  85. Natural History of Indeterminate Liver Nodules in Patients With Advanced Liver Disease: A Multicenter Retrospective Cohort Study
    Amit G. Singal, Neehar D. Parikh, Kirti Shetty, Steven‐Huy B. Han, Cassie Xie, Jing Ning, Jo Ann Rinaudo, Ashwini Arvind, Anna Suk-Fong Lok, Fasiha Kanwal et al. · 2024 · The American Journal of Gastroenterology
  86. Advances and Challenges in Hepatocellular Carcinoma: A Comprehensive Review
    Mateusz Dorochowicz, Aleksandra Krzemienowska-Cebulla, Iwona Matus, Hanna Senat · 2023 · Journal of Education Health and Sport
  87. Surveillance for hepatocellular carcinoma - current status and advances
    Kaina Chen, Jason Pik-Eu Chang, George Boon‐Bee Goh, Chee‐Kiat Tan · 2018 · Hepatoma Research
  88. Performance of SPINK1 and SPINK1‐based diagnostic model in detection of hepatocellular carcinoma
    Fang Wang, Hui Liu, Youxi Bai, Hui Li, Zhonglin Wang, Xin Xu · 2021 · Journal of Clinical Laboratory Analysis
  89. Diagnosis and management of indeterminate liver nodules in patients with cirrhosis
    Mounika Kanneganti, Amit G. Singal · 2023 · Clinical Liver Disease
  90. Machine learning approach to predict blood-secretory proteins and potential biomarkers for liver cancer using omics data
    Dahrii Paul, Vigneshwar Suriya Prakash Sinnarasan, Rajesh Das, Md Mujibur Rahman Sheikh, Amouda Venkatesan · 2024 · Journal of Proteomics
  91. Surveillance for Hepatocellular Carcinoma
    Eleanor Taylor, Ian A.C. Rowe · 2018 · Springer eBooks
  92. Integrated Predictors by Propensity Scoring With Tumor Markers and Plasma Levels of microRNA-21-5p, IL-17, and IL-10 Complement Early Detection of Hepatocellular Carcinoma in Patients With Liver Cirrhosis
    Maiko Machida, Mayuko Ambo, Runa Mishina, Nanaka Hada, Fuhito Tachibana, Miki Yamashita, Ainari Konda, Kunihiko Tsuji · 2023 · Technology in Cancer Research & Treatment
  93. Novel Blood-Based Biomarkers for HCC
    Suraj Pai, Neehar D. Parikh · 2024 · Current Hepatology Reports
  94. Cell Cycle-Related LncRNA-Based Prognostic Model for Hepatocellular Carcinoma: Integrating Immune Microenvironment and Treatment Response
    Lin Chen, Guozhi Wu, Tao Wu, Hao-Hu Shang, Wei-juan Wang, David P. Fisher, Nguyen Thi Thu Hiens, Erkin Isakovich Musabaev, Lei Zhao · 2024 · Current Medical Science
  95. Predicting early recurrence of hepatocellular carcinoma after thermal ablation based on longitudinal MRI with a deep learning approach
    Qingyang Kong, Kai Li · 2025 · The Oncologist
  96. Rationalising Hepatocellular Carcinoma Screening in Chronic Hepatitis B: Evaluation of Predictive Scores in an Australian Cohort
    Thisuri Jayawardena, Zein Salim, Luis Calzadilla Bertot, Joanne Bunney, Nicolas Demasi, Joanne Vallve, Leon Anton Adams, Gary P. Jeffrey, David John Speers, Gerry C. MacQuillan et al. · 2025 · Liver International
  97. Continued value of the serum alpha-fetoprotein test in surveilling at-risk populations for hepatocellular carcinoma
    Jihyun An, Ha Il Kim, Seheon Chang, Ju Hyun Shim · 2020 · PLoS ONE
  98. Non-contrast abbreviated MRI for the detection of hepatocellular carcinoma in patients with Liver Imaging Reporting and Data System LR-3 and LR-4 observations in MRI
    Soe Thiha Maung, Natthaporn Tanpowpong, Minchanat Satja, Sombat Treeprasertsuk, Roongruedee Chaiteerakij · 2024 · British Journal of Radiology
  99. PRO: Hepatocellular Carcinoma Surveillance: A Useful Tool Against the Rising Tide of HCC
    Neehar D. Parikh · 2017 · The American Journal of Gastroenterology
  100. Editorial: ultrasound surveillance of hepatocellular carcinoma in the 21st century
    Deep N. Patel · 2017 · Alimentary Pharmacology & Therapeutics